Boehringer Ingelheim has over 90 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.
Follow our character Mike, as he gets through his day with asthma. Almost 1 in 2 people with asthma still experience symptoms, but they don’t have to. Watch the video on www.thinkactbreathe.com, take our quiz and find out what more can be done.